These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 28427991

  • 1. Impact of the pneumococcal conjugate vaccine on serotype distribution of adult non-invasive Streptococcus pneumoniae isolates in Tokai region, Japan, 2008-2016.
    Furuya Y, Yamagishi Y, Okade H, Kadota T, Funatsu T, Eto M, Nomura N, Mitsuyama J, Mikamo H.
    J Infect Chemother; 2017 Jun; 23(6):394-399. PubMed ID: 28427991
    [Abstract] [Full Text] [Related]

  • 2. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period.
    Okade H, Funatsu T, Eto M, Furuya Y, Mizunaga S, Nomura N, Mitsuyama J, Yamagishi Y, Mikamo H.
    J Infect Chemother; 2014 Jul; 20(7):423-8. PubMed ID: 24802765
    [Abstract] [Full Text] [Related]

  • 3. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae strains isolated in Japan after introduction of the routine immunization program.
    Miyazaki H, Shibuya R, Midorikawa N, Chang B, Ohnishi M, Matsumoto T.
    J Infect Chemother; 2017 Apr; 23(4):234-240. PubMed ID: 28161295
    [Abstract] [Full Text] [Related]

  • 4. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S, Fujisawa T, Ito Y, Chang B, Suga S, Noguchi T, Yamamoto M, Matsumura Y, Nagao M, Takakura S, Ohnishi M, Ihara T, Ichiyama S.
    Vaccine; 2016 Jan 02; 34(1):67-76. PubMed ID: 26602268
    [Abstract] [Full Text] [Related]

  • 5. Epidemiological and molecular characterization of invasive Streptococcus pneumoniae isolated following introduction of 7-valent conjugate vaccine in Kinki region, Japan, 2008-2013.
    Toda H, Tanaka Y, Satoh K, Komatsu M, Wada Y, Tobe T, Kamisako T.
    J Infect Chemother; 2020 May 02; 26(5):451-458. PubMed ID: 31870586
    [Abstract] [Full Text] [Related]

  • 6. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction.
    Gladstone RA, Jefferies JM, Tocheva AS, Beard KR, Garley D, Chong WW, Bentley SD, Faust SN, Clarke SC.
    Vaccine; 2015 Apr 21; 33(17):2015-21. PubMed ID: 25776920
    [Abstract] [Full Text] [Related]

  • 7. Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccine.
    Suga S, Chang B, Asada K, Akeda H, Nishi J, Okada K, Wakiguchi H, Maeda A, Oda M, Ishiwada N, Saitoh A, Oishi T, Hosoya M, Togashi T, Oishi K, Ihara T.
    Vaccine; 2015 Nov 09; 33(45):6054-60. PubMed ID: 26235372
    [Abstract] [Full Text] [Related]

  • 8. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.
    Camilli R, D'Ambrosio F, Del Grosso M, Pimentel de Araujo F, Caporali MG, Del Manso M, Gherardi G, D'Ancona F, Pantosti A, Pneumococcal Surveillance Group.
    Vaccine; 2017 Aug 16; 35(35 Pt B):4587-4593. PubMed ID: 28716556
    [Abstract] [Full Text] [Related]

  • 9. Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia.
    Mokaddas EM, Shibl AM, Elgouhary A, Elsobky M.
    Vaccine; 2018 Oct 15; 36(43):6442-6448. PubMed ID: 30194003
    [Abstract] [Full Text] [Related]

  • 10. Serotype distribution and susceptibility to penicillin and erythromycin among noninvasive or colonization isolates of Streptococcus pneumoniae in northern Japan: a cross-sectional study in the pre-PCV7 routine immunization period.
    Kawaguchiya M, Urushibara N, Ghosh S, Kuwahara O, Morimoto S, Ito M, Kudo K, Kobayashi N.
    Microb Drug Resist; 2014 Oct 15; 20(5):456-65. PubMed ID: 24766085
    [Abstract] [Full Text] [Related]

  • 11. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E, Albert MJ.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [Abstract] [Full Text] [Related]

  • 12. Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015.
    Kaur R, Casey JR, Pichichero ME.
    Pediatr Infect Dis J; 2016 Aug 31; 35(8):901-6. PubMed ID: 27420806
    [Abstract] [Full Text] [Related]

  • 13. Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: Comparison of carried and clinical pneumococcal isolates from the same time period in Hungary.
    Kovács E, Sahin-Tóth J, Tóthpál A, Kristóf K, van der Linden M, Tirczka T, Dobay O.
    Vaccine; 2019 Jan 03; 37(1):99-108. PubMed ID: 30470639
    [Abstract] [Full Text] [Related]

  • 14. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
    Parra EL, De La Hoz F, Díaz PL, Sanabria O, Realpe ME, Moreno J.
    Vaccine; 2013 Aug 20; 31(37):4033-8. PubMed ID: 23680440
    [Abstract] [Full Text] [Related]

  • 15. Serotype distribution, antimicrobial resistance and prevalence of pilus islets in pneumococci following the use of conjugate vaccines.
    Kawaguchiya M, Urushibara N, Aung MS, Shinagawa M, Takahashi S, Kobayashi N.
    J Med Microbiol; 2017 May 20; 66(5):643-650. PubMed ID: 28516842
    [Abstract] [Full Text] [Related]

  • 16. The changing phenotypes and genotypes of invasive pneumococcal isolates from children in Shenzhen during 2013-2017.
    Bao Y, Wang Q, Yao K, Xie G, Gao W, Huang L, Liu X, Zhu C, Chen H, Wang H, Shen K, Zheng Y, Yang Y.
    Vaccine; 2019 Nov 20; 37(49):7248-7255. PubMed ID: 31635974
    [Abstract] [Full Text] [Related]

  • 17. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
    Charfi F, Smaoui H, Kechrid A.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G18-24. PubMed ID: 23228353
    [Abstract] [Full Text] [Related]

  • 18. High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive/colonization isolates of Streptococcus pneumoniae: A cross-sectional study eight years after the licensure of conjugate vaccine in Japan.
    Kawaguchiya M, Urushibara N, Aung MS, Ito M, Takahashi A, Habadera S, Kobayashi N.
    J Infect Public Health; 2020 Aug 31; 13(8):1094-1100. PubMed ID: 32446777
    [Abstract] [Full Text] [Related]

  • 19. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM, Memish ZA, Al-Kattan KM.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae.
    Dagan R, Juergens C, Trammel J, Patterson S, Greenberg D, Givon-Lavi N, Porat N, Gurtman A, Gruber WC, Scott DA.
    J Infect Dis; 2015 Apr 01; 211(7):1144-53. PubMed ID: 25355940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.